ArticleJournal of clinical epidemiology2018

Design analysis indicates Potential overestimation of treatment effects in randomized controlled trials supporting Food and Drug Administration cancer drug approvals.

Emily M Lord et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.